$25.74
0.040.16%
Pre-Market: 6:37 AM EDT
Comments
Loading...
Viking Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:VKTX | Benzinga
Viking Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 23
EPS Estimate
$-0.280
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Viking Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Viking Therapeutics (VKTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-05 | $-0.32 | $-0.27 | -18.5 % |
| Q3 | 2024-10-23 | $-0.22 | $-0.25 | 12.0 % |
| Q2 | 2024-07-24 | $-0.20 | $-0.27 | 25.9 % |
| Q1 | 2024-04-24 | $-0.26 | $-0.28 | 7.14 % |
Viking Therapeutics (VKTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?
Viking Therapeutics (VKTX) is scheduled to report earnings on April 23, 2025. The last reported earnings were for reported on February 5, 2025 for Q4.
What were the latest earnings per share (EPS) for Viking Therapeutics (NASDAQ:VKTX)?
The Actual EPS was $-0.32, which missed the estimate of $-0.27.
What were Viking Therapeutics’s (NASDAQ:VKTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.